Zentalis Pharmaceuticals, Inc.ZNTLNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-134.01M
Near historical average
Percentile
P57
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
$-123.94M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-134.01M | +21.7% |
| 2024 | $-171.08M | +17.9% |
| 2023 | $-208.41M | -25.3% |
| 2022 | $-166.30M | -3.8% |
| 2021 | $-160.20M | -82.9% |
| 2020 | $-87.58M | -121.8% |
| 2019 | $-39.49M | -61.3% |
| 2018 | $-24.48M | - |